Cosmetics and pharmaceutical applications of gallic acid and gallic acid derivatives
AssigneesGreenpharma, Bioalternatives SAS
InventorsPhilippe BERNARD, François-Xavier BERNARD, Franck HIMBERT
Life of this patent
Estimating the term…
Abstract
The present invention concerns a compound, a salt of this compound, a derivative of this compound or a salt of this derivative, said compound being chosen among the gallic acid, its hydrolyzable polymers in gallic acid, the hexahydroxydiphenic acid, its hydrolyzable polymers in hexahydroxydiphenic acid, the ellagic acid, its hydrolyzable polymers in ellagic acid, the gallotannins, the ellagitannins, and its cosmetic applications for stimulating or repairing the barrier function of the epidermis and its pharmaceutical applications for treating lesions caused by pathologies, such as Crohn's disease.
Claims20
A use of a compound, of a salt of this compound or of a derivative of this compound or of a salt of this derivative, said compound being chosen among the gallic acid, its hydrolyzable polymers in gallic acid, the hexahydroxydiphenic acid, its hydrolyzable polymers in hexahydroxydiphenic acid, the ellagic acid, its hydrolyzable polymers in ellagic acid, the gallotannins, the ellagitannins, as an active ingredient in a cosmetic composition for stimulating or repairing the barrier function of the epidermis.
A compound, a salt of this compound, a derivative of this compound or a salt of this derivative, said compound being chosen among the gallic acid, its hydrolyzable polymers in gallic acid, the hexahydroxydiphenic acid, its hydrolyzable polymers in hexahydroxydiphenic acid, the ellagic acid, its hydrolyzable polymers in ellagic acid, the gallotannins, the ellagitannins, for use in the treatment of lesions caused by Crohn's disease or in the treatment of lesions associated to atopic dermatitis, eczema, psoriasis, seborrheic dermatitises and acne.
A pharmaceutical composition for use in the treatment of lesions caused by Crohn's disease or in the treatment of lesions associated to atopic dermatitis, eczema, psoriasis, seborrheic dermatitises and acne, characterized in that it comprises a compound, a salt of a compound, a derivative of a compound or a salt of a derivative, compatible with a pharmaceutical use, said compound being chosen among the gallic acid, its hydrolyzable polymers in gallic acid, the hexahydroxydiphenic acid, its hydrolyzable polymers in hexahydroxydiphenic acid, the ellagic acid, its hydrolyzable polymers in ellagic acid, the gallotannins, the ellagitannins.
Dependencies are inferred from the claim text.